Repigmentation in two patients with vitiligo on AcEGCG 0.5% cream.

Hu, Wenting; Jin, Rong; Lin, Fuquan; Lei, Jiehao; Ma, Yangyang; Xu, Ai-E

Hu, Wenting; Jin, Rong; Lin, Fuquan; Lei, Jiehao; Ma, Yangyang; Xu, Ai-E.

Afiliação

Hu W; Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou, China.
Jin R; Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou, China.
Lin F; Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou, China.
Lei J; Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou, China.
Ma Y; Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou, China.
Xu AE; Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou, China.

Clin Exp Dermatol ; 47(9): 1760-1761, 2022 Sep.

Article em En | MEDLINE | ID: mdl-35731108

ABSTRACT

ABSTRACT

Per-acetylated epigallocatechin-3-gallate (AcEGCG), a fully acetylated derivative of EGCG, a more potent agent for protection of melanocytes from oxidative damage. We present two patients with vitiligo treated with AcEGCG 0.5% cream, who demonstrated skin repigmentation and control of depigmentation progression.

Assuntos

Catequina; Pigmentação da Pele; Vitiligo; Catequina/análogos & derivados; Catequina/uso terapêutico; Emolientes; Humanos; Melanócitos; Estresse Oxidativo; Vitiligo/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vitiligo / Pigmentação da Pele / Catequina Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google